12.02.2013 Views

New Modes of GPCR Signalling

New Modes of GPCR Signalling

New Modes of GPCR Signalling

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

INVITED SPEAKER’S INFO<br />

Pr<strong>of</strong>. Yong Shen<br />

PhD, Senior scientist/Pr<strong>of</strong>essor<br />

Haldeman Laboratory <strong>of</strong> Molecular and Cellular<br />

Neurobiology<br />

Sun Health Research Institute<br />

10515 West Santa Fe Drive, Sun City, AZ, 85351, U.S.A.<br />

Phone: (623)876-5456<br />

Fax: (623)876-6688<br />

Email: Yong.Shen@bannerhealth.com<br />

Education<br />

1983 Nanjing University, China BSc. Physiology<br />

1986 Shanghai Inst. <strong>of</strong> Physiology, Academy <strong>of</strong> Sciences MSc. Neurophysiology<br />

1989 State University <strong>of</strong> <strong>New</strong> York (SUNY) Ph.D. Neuroscience<br />

Selected Publications<br />

1. Ewers M, Cheng X, Nural HF, Walsh C, Meindl T, Teipel SJ, Buerger K, Shen Y,<br />

Hampel H. (2010). CSF- BACE1 activity predicts hippocampus atrophy in<br />

Alzheimer’s disease. J Alzheimers Dis, Apr 26.<br />

2. Cheng X., Yang L., He P, Li R., Shen Y. (2010). Differential activation <strong>of</strong> TNF<br />

receptors distinguishes Alzheimer from normal brains. J Alzheimers Dis,<br />

19(2):621-30.<br />

3. Ghosal P., Vogt D, Man L, Shen Y., Lamb B., Pimplikar, SW (2009). Alzheimer's<br />

disease-like pathological features in transgenic mice expressing the APP<br />

intracellular domain. Proc Natl Acad Sci U S A. 106(43): 18367-18377.<br />

4. He, P., Staufenbiel M and Shen, Y. (2008). Interruption <strong>of</strong> β-catenin signaling<br />

reduces neurogenesis in Alzheimer’s disease’s brains. Nature Proceedings,<br />

September, and J.Neurosci. (2009), 29(20):6545-57.<br />

5. The paper is selected as World Faculty 1000 and Feature Article Xia W., Yang T.,<br />

Imelda M. Smith I. M., Shen Y., Walsh D. M. and Dennis J. Selkoe, D. J. (2009). A<br />

specific ELISA for measuring amyloid β-protein oligomers in human plasma and<br />

the brains <strong>of</strong> Alzheimer patients. Archives <strong>of</strong> Neurology, 66(2):190-9.<br />

6. Nural F., He P, Beach T, Sue L, Xia W, and ShenY. (2009). Disassembled DJ-1<br />

high molecular weight complex in cortex in cortex mitochondria from Parkinson’s<br />

disease Patients. Molecular Neurodegeneration.<br />

7. Kozikowski, A. P., Chen, Y., Subahasish, T., Zhong, Z., Melissa A. D’Annibale,<br />

M.A., Shen, Y. and Langley, B.C. (2010). PKC activation and HDAC inhibition -A<br />

dual drug approach to Alzheimer’s disease that reduces Aβ production while<br />

blocking oxidative stress. Proc Natl Acad Sci U S A.. Submitted.<br />

8. Chirapu, S. R, Pachaiyappan, B, Zhong, Z., Abdul-Hay, S. O., Yuan, H., Thatcher,<br />

G., Shen, Y., Kozikowski, A. P, Petukhov, P. A. (2008). Molecular modeling,<br />

Synthesis and Activity Studies <strong>of</strong> Inhibitors Targeting Alzheimer’s disease

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!